ATCC was selected by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to provide vital cell lines to academic, pharmaceutical, and biotechnology organizations committed to speeding the progress toward a cure for Parkinson’s disease. In this first of three interviews, Dr. Brian Shapiro, a Marketing Segment Manager at ATCC, met with Dr. Elisia Clark, an Associate Director of Research Programs at MJFF, and Dr. Birgitt Schüle, an Associate Professor in the Department of Pathology at Stanford University School of Medicine, to discuss MJFF’s mission and how the cell lines made available through the collaboration between MJFF and ATCC aids Parkinson’s Disease research.